November 8, 2017

A research partnership between PlantForm Corporation and a University of Calgary scientist has been awarded an Engage Grant from the Natural Sciences and Engineering Research Council of Canada.

The funding will allow Dr. Douglas Muench, Professor of Integrative Cell Biology at the University of Calgary, to study the potential for a novel RNA-binding protein to increase the expression rate of monoclonal antibodies produced in plant cells. The research study will focus specifically on the monoclonal antibody trastuzumab with the goal of developing an enhanced protein expression technology that can be universally applied to any high-value protein of interest.

read full news report here: